HSP90: An Emerging Molecular Target for Improvement of Nanoparticle Based Magnetic Hyperthermia Therapy

This publication has 58 references indexed in Scilit:

• Heat shock protein 90 (HSP90) inhibitors in gastrointestinal cancer: where do we currently stand?—A systematic review
  Journal of Cancer Research and Clinical Oncology, 2023
• Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities
  Medcomm, 2022
• Recent advances in heat shock proteins in cancer diagnosis, prognosis, metabolism and treatment
  Biomedicine & Pharmacotherapy, 2021
• The role and therapeutic potential of Hsp90, Hsp70, and smaller heat shock proteins in peripheral and central neuropathies
  Medicinal Research Reviews, 2020
• Iron-oxide nanoparticles target intracellular HSP90 to induce tumor radio-sensitization
  Biochimica et Biophysica Acta (BBA) - General Subjects, 2019
• Inhibition of Hsp90 and 70 sensitizes melanoma cells to hyperthermia using ferromagnetic particles with a low Curie temperature
  International Journal of Clinical Oncology, 2013
• Hsp90: Structure and Function
  2012
• Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012
• Extracellular heat shock proteins, cellular export vesicles, and the Stress Observation System: A form of communication during injury, infection, and cell damage
  Cell Stress and Chaperones, 2010
• New developments in Hsp90 inhibitors as anti-cancer therapeutics: Mechanisms, clinical perspective and more potential
  Drug Resistance Updates, 2009